Add like
Add dislike
Add to saved papers

La 0.8 Sr 0.2 MnO 3 -Based Perovskite Nanoparticles with the A-Site Deficiency as High Performance Bifunctional Oxygen Catalyst in Alkaline Solution.

Perovskite (La0.8 Sr0.2 )1-x Mn1-x Irx O3 (x = 0 (LSM) and 0.05 (LSMI)) nanoparticles with particle size of 20-50 nm are prepared by the polymer-assisted chemical solution method and demonstrated as high performance bifunctional oxygen catalyst in alkaline solution. As compared with LSM, LSMI with the A-site deficiency and the B-site iridium (Ir)-doping has a larger lattice, lower valence state of transition metal, and weaker metal-OH bonding; therefore, it increases the concentration of oxygen vacancy and enhances both oxygen evolution reaction (OER) and oxygen reduction reaction (ORR). LSMI exhibits superior ORR performance with only 30 mV onset potential difference from the commercial Pt/C catalyst and significant enhancement in electrocatalytic activity in the OER process, resulting in the best oxygen electrode material among all the reported perovskite oxides. LSMI also exhibits high durability for both ORR (only 18 mV negative shift for the half-wave potential compared with the initial ORR) and OER process with 10% decay. The electrochemical results indicate that the A-site deficiency and Ir-doping in perovskite oxides could be promising catalysts for the applications in fuel cells, metal-air batteries, and solar fuel synthesis.

Full text links

We have located links that may give you full text access.
Can't access the paper?
Try logging in through your university/institutional subscription. For a smoother one-click institutional access experience, please use our mobile app.

Related Resources

For the best experience, use the Read mobile app

Mobile app image

Get seemless 1-tap access through your institution/university

For the best experience, use the Read mobile app

All material on this website is protected by copyright, Copyright © 1994-2024 by WebMD LLC.
This website also contains material copyrighted by 3rd parties.

By using this service, you agree to our terms of use and privacy policy.

Your Privacy Choices Toggle icon

You can now claim free CME credits for this literature searchClaim now

Get seemless 1-tap access through your institution/university

For the best experience, use the Read mobile app